LENTIVERSE™ LaunchSuite: Point-Of-Care CAR-T Manufacturing Built For Clinical Environments

Traditional lentiviral vector manufacturing models were not designed around the clinical environment for accessible CAR-T production. LaunchSuite was.

Built for healthcare institutions seeking a more practical path to point-of-care manufacturing, LaunchSuite brings together the elements required to support repeatable CAR-T execution closer to where patients receive treatment. Rather than treating manufacturing location as a logistical afterthought, LaunchSuite treats it as a core design variable.

The result is a care-aligned framework intended to reduce workflow burden, simplify operational complexity, and support more predictable execution across known CAR-T use cases.

Key advantages of LENTIVERSE™ LaunchSuite:

• Manufacture where care happens: Designed to support CAR-T production models closer to the point of treatment, reducing reliance on distant centralized workflows.
• Institution-ready by design: Built around the operational realities of clinical facilities, with a focus on repeatability, cadence, and practical deployment.
• Stabilized execution path: Suited for programs based on established CAR-T targets where consistency and controllability matter more than iterative development.
• Simplified process architecture: Helps reduce facility burden, specialized operator dependency, and workflow fragmentation through a more streamlined operating model.
• Cost architecture with access in mind: Addresses structural cost drivers that can limit broader deployment of advanced therapies.
• Regulatory foresight built in: Developed with comparability, data capture, tech transfer, and distributed manufacturing scrutiny in view.

For institutions working to bring CAR-T manufacturing closer to patients, LaunchSuite provides a more operationally grounded path forward.